Bevacizumab and chest pain Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5852385-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Male patient, weighting 114.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, chest pain
, chronic obstructive pulmonary disease, diarrhoea, metastasis. Bevacizumab dosage: 15 MG/KG (777MG) Q 21 DAYS IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5914058-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 25, 2008. Male patient was diagnosed with renal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 675 MG, UNK. During the same period patient was treated with INTERFERON ALFA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4925960-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 24, 2006. Male patient, 64 years of age, weighting 242.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac arrest
, chest pain
, dysarthria, nausea
, speech disorder, tremor, ventricular fibrillation. Bevacizumab dosage: 5MG/KG = 550 MG. During the same period patient was treated with OXALIPLATIN IV, LEUKOVORIN IV, FLUOROURACIL, TYLENOL, ZOFRAN, DECADRON SRC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4941370-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2006. Male patient, 64 years of age, weighting 242.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac arrest
, chest pain
, dysarthria, ejection fraction decreased, electrocardiogram qt corrected interval prolonged, nausea
, tremor, ventricular dysfunction. Bevacizumab dosage: 5 MG/KG =550 MG. During the same period patient was treated with OXALIPLATIN IV, LEUKOVORIN IV, TYLENOL, ZOFRAN, DECADRON SRC, COMPAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4981907-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2006. Male patient, weighting 420.2 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood sodium decreased, chest pain
, dyspnoea. Bevacizumab dosage: 15MG/KG Q 21-DAYS IV DRIP. During the same period patient was treated with ERLOTINIB, IBUPROFEN, PROTONIX, REGLAN, CLEOCIN T. Patient recovered.Bevacizumab Side Effects Report #4760940-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 18, 2005. Female patient, 63 years of age, weighting 164.2 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, body temperature decreased, bundle branch block, chest pain
, chills, computerised tomogram abnormal, crepitations, dizziness
, dysphonia. Bevacizumab dosage: 1118 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, EFFEXOR, COMPAZINE, WARFARIN, DOCUSATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4971693-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 27, 2006. Female patient, 63 years of age, weighting 164.2 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bundle branch block left, chest pain
, chills, computerised tomogram abnormal, crepitations, dilatation ventricular, dizziness
, dysphonia. Bevacizumab dosage: 1118 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, EFFEXOR, VITAMIN, COMPAZINE, WARFARIN, DOCUSATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5004595-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 01, 2006. Male patient, 50 years of age, weighting 190.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, atelectasis, blood alkaline phosphatase increased, blood pressure decreased, bronchopneumonia, cardio-respiratory arrest, chest pain
, cough, decreased appetite. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died on 09/26/2005.Bevacizumab Side Effects Report #5019116-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 16, 2006. Male patient, 63 years of age, weighting 134.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, blood sodium increased, body temperature decreased, cardiac index decreased, chest discomfort, chest pain
, dizziness
, electrocardiogram st segment, electrocardiogram st segment elevation. Bevacizumab dosage: 920 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMZAR, CARBOPLATIN, TYCO #, ZOFRAN, LOMOTIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5028198-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 30, 2006. Male patient, 63 years of age, weighting 134.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood pressure decreased, blood sodium decreased, body temperature decreased, chest discomfort, chest pain
, dizziness
, fall
, fibrin d dimer increased. Bevacizumab dosage: 920 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMZAR, CARBOPLATIN, TYCO #, ZOFRAN, LOMOTIL, NEUPOGEN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5511765-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 26, 2007. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5554917-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 03, 2007. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE, JODID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5611674-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 22, 2008. Male patient, weighting 147.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, OLMESARTAN MEDOXOMIL, CRESTOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5612964-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 21, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE. Patient was hospitalized. Patient died on 01/07/2008.Bevacizumab Side Effects Report #5635454-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 08, 2008. Male patient, weighting 147.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, OLMESARTAN MEDOXOMIL, CRESTOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5639515-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension, oedema peripheral. Bevacizumab dosage: 810 MG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5663512-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 03, 2008. Male patient, weighting 147.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, OLMESARTAN MEDOXOMIL, CRESTOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5669156-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 04, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension, oedema peripheral. Bevacizumab dosage: 810 MG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5669964-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 05, 2008. Female patient, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism
, vomiting. Bevacizumab dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMZAR, CARBOPLATIN, NOVALGIN, OMEPRAZOLE, FENTANYL, LERCANIDIPINE. Patient was hospitalized. Patient died on 01/07/2008.Bevacizumab Side Effects Report #5698388-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension, oedema peripheral. Bevacizumab dosage: 810 MG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5957205-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension, oedema peripheral. Bevacizumab dosage: 810 MG, QD. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5989130-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chest pain
, troponin t increased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CETUXIMAB, PACLITAXEL, CARBOPLATIN. Patient recovered.Bevacizumab Side Effects Report #4993515-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2006. Female patient, weighting 169.1 lb, was diagnosed with neuroendocrine tumour, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aortic thrombosis, back pain
, blood pressure increased, chest pain
, dyspnoea, vomiting. Bevacizumab dosage: 375 MG QS Q 2 WEEKS IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5211798-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2007. Male patient, 49 years of age, weighting 206.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pneumonia
. Bevacizumab dosage: 937 MG Q 14 DAYS IV. During the same period patient was treated with PROLEUKIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4887657-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Female patient, 71 years of age, weighting 126.1 lb, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chest pain
, dehydration, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral, thrombosis. Bevacizumab dosage: 858 MG ., QD/DAYS IV. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5284093-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Female patient, 65 years of age, weighting 108.0 lb, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, sinus tachycardia. Bevacizumab dosage: 743 MG, Q3W, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5373292-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2007. Female patient, weighting 119.0 lb, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, back pain
, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood sodium decreased, chest pain
. Bevacizumab dosage: 15 MG/KG EVERY 21 DAYS IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5383541-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 02, 2007. Female patient, weighting 108.0 lb, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 743 MG, Q3W. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5668725-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2008. Female patient, 67 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, chest pain
, dehydration, nausea
. Bevacizumab dosage: 10 MG/KG, IV Q2WKS. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5232175-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2007. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, disease progression, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5144360-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, somnolence. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient recovered.Bevacizumab Side Effects Report #5155827-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 03, 2006. Female patient, 59 years of age, weighting 219.8 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: caecitis, cerebral haemorrhage, chest pain
, dehydration, haematocrit decreased, mental status changes, neutropenia, red blood cell count decreased, thrombocytopenia. Bevacizumab dosage: 997 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN, CEFTAZIDIME, NEUPOGEN, DEXAMETHASONE, OXYGEN, RANITIDINE, FUROSEMIDE, OCTREOTIDE ACETATE. Patient was hospitalized and became disabled. Patient died.Bevacizumab Side Effects Report #5809323-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 01, 2008. Female patient was diagnosed with endometrial cancer, anxiety
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, cholecystitis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ZOLOFT. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5007331-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, weighting 169.1 lb, was diagnosed with endocrine pancreatic disorder, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, aortic disorder, blood pressure diastolic decreased, chest pain
, condition aggravated, dehydration, haematoma, hypertension, jejunal ulcer. Bevacizumab dosage: 37.5 MG QS, Q 2 WEEKS, IV. During the same period patient was treated with DEXAMETHASONE, ALOXI, OXALIPLATIN, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5319336-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 27, 2007. Male patient was diagnosed with colorectal cancer metastatic, prophylaxis, nausea
, constipation
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ACETYLSALICYLIC ACID SRT, GLUCOSAMINE, PROCHLORPERAZINE EDISYLATE, MACROGOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5328168-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, weighting 148.8 lb, was diagnosed with colorectal cancer metastatic, pain
, pulmonary embolism
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, body temperature decreased, cardiomegaly, chest pain
, fibrin d dimer increased, large intestine perforation, odynophagia, pneumatosis intestinalis, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, PERCOCET, LOVENOX, COUMADIN, OXYCONTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5987586-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 24, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 510 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, SIMVASTATIN. Patient died on 11/19/2008.Bevacizumab Side Effects Report #4614898-5
Bevacizumab side effect was reported by a Pharmacist from on Mar 18, 2005. Male patient, 59 years of age, weighting 179.7 lb, was diagnosed with colon cancer stage iv and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Bevacizumab dosage: 400MG, INFUSE O, INTRAVEN. Patient recovered.Bevacizumab Side Effects Report #5331776-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Male patient, 73 years of age, weighting 155.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, blood pressure decreased, chest pain
, odynophagia, pneumatosis intestinalis, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG IV Q 2 WEEKS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, CETUXIMAB, PERCOCET. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5395604-6
Bevacizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on July 06, 2007. Female patient, weighting 127.9 lb, was diagnosed with colon cancer, colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety
, chest pain
. Bevacizumab dosage: 285 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ACETAMINOPHEN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5425447-6
Bevacizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Aug 10, 2007. Female patient, weighting 127.9 lb, was diagnosed with colon cancer, colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety
, chest pain
. Bevacizumab dosage: 285 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, PARACETAMOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5945652-X
Bevacizumab side effect was reported by a Physician from SWITZERLAND on Oct 24, 2008. Female patient, weighting 127.9 lb, was diagnosed with colon cancer, colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety
, chest pain
. Bevacizumab dosage: 285 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ACETAMINOPHEN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6018119-0
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Dec 08, 2008. Male patient was diagnosed with colon cancer, insomnia, gastrooesophageal reflux disease, psychotic disorder
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pericarditis. Bevacizumab dosage: 580 MG, Q3W. During the same period patient was treated with CAPECITABINE, NITRAZEPAM, RANITIDINE, ZYPREXA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6089759-8
Bevacizumab side effect was reported by a Physician from AUSTRALIA on Feb 11, 2009. Male patient was diagnosed with colon cancer, insomnia, gastrooesophageal reflux disease, psychotic disorder
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriospasm coronary, chest pain
. Bevacizumab dosage: 580 MG, Q3W. During the same period patient was treated with CAPECITABINE, NITRAZEPAM, RANITIDINE, ZYPREXA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5297519-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Female patient, 61 years of age, weighting 131.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Bevacizumab dosage: 620 MG, Q2W. During the same period patient was treated with PACLITAXEL, ATIVAN, COMPAZINE, NEULASTA, ARANESP. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5316717-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Female patient, 61 years of age, weighting 131.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Bevacizumab dosage: 620 MG, Q2W. During the same period patient was treated with PACLITAXEL, ATIVAN, COMPAZINE, NEULASTA, ARANESP. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5478653-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 06, 2007. Female patient, 59 years of age, weighting 140.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, chest pain
. Bevacizumab dosage: 960 MG/KG, UNK. During the same period patient was treated with HERCEPTIN, DOCETAXEL, CARBOPLATIN, PEGFILGRASTIM, ZOFRAN, COMPAZINE, EMEND, OXYCODONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5443472-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension. Bevacizumab dosage: 1775 MG, Q3W. During the same period patient was treated with TAXOTERE, PROZAC, DARVON, KEFLEX, NIFEDIPINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5464502-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, hypertension. Bevacizumab dosage: 1775 MG, Q3W. During the same period patient was treated with TAXOTERE, PROZAC, DARVON, KEFLEX, NIFEDIPINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5638640-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient, weighting 154.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, perineal abscess, sepsis syndrome. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, ABRAXANE, PROTONIX, WELLBUTRIN, ASPIRIN, ZOSYN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5638640-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient, weighting 154.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, perineal abscess, sepsis syndrome. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, ABRAXANE, PROTONIX, WELLBUTRIN, ASPIRIN, ZOSYN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5887024-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with VORINOSTAT, TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5958781-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, hyperglycaemia, thrombosis. Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with VORINOSTAT, TAXOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5998027-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
. Bevacizumab dosage: 10 MG/KG, Q28D. During the same period patient was treated with VORINOSTAT, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5469272-9
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Sept 26, 2007. Male patient, 54 years of age, weighting 249.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: apnoea, brain stem ischaemia, cardio-respiratory arrest, chest discomfort, chest pain
, hemiparesis, ischaemic stroke, loss of consciousness, pulse absent. Bevacizumab dosage: 1.25 MG ONCE. Patient died on 09/03/2007.Bevacizumab Side Effects Report #5206956-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2007. Male patient, weighting 190.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, pulmonary embolism
. Bevacizumab dosage: 1720 MG. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5742361-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dizziness
, dyspnoea, headache
, hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5749692-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2008. Female patient, weighting 200.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain
, dizziness
, dyspnoea, headache
, hypertension. Bevacizumab dosage: 439 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab and chest pain 